Mark J. O’Connor

AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity

Jacqueline H. L. Fok, Antonio Ramos‐Montoya, Mercedes Vázquez–Chantada et al. · Nature Communications · 2019 · 334 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer

Yung‐Jue Bang, Seock‐Ah Im, Keun‐Wook Lee et al. · Journal of Clinical Oncology · 2015 · 294 citations · Full text

Medicine, Oncology, Pharmacology +15

Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations

Tian Ge, Marguerite R. Irvin, Amit Patki et al. · Genome Medicine · 2022 · 173 citations · Full text

Life Sciences, Biostatistics, Genetics +17

Assessing the Causal Relationships Between Insulin Resistance and Hyperuricemia and Gout Using Bidirectional Mendelian Randomization

Natalie McCormick, Mark J. O’Connor, Chio Yokose et al. · Arthritis & Rheumatology · 2021 · 166 citations · Full text

Life Sciences, Endocrinology, Genetics +17

Systolic and Diastolic Mechanics in Stress Cardiomyopathy

Keith Medeiros, Mark J. O’Connor, Catalin F. Baicu et al. · Circulation · 2014 · 123 citations · Full text

Medicine, Cardiology, Physiology +13